{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:32:40Z","timestamp":1794105160505,"version":"4.8.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.xcrm.2024.101878","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T15:32:17Z","timestamp":1734708737000},"page":"101878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Metabolic profiling of patient-derived organoids reveals nucleotide synthesis as a metabolic vulnerability in malignant rhabdoid tumors"],"prefix":"10.1016","volume":"6","author":[{"given":"Marjolein M.G.","family":"Kes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Morales-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther A.","family":"Zaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terezinha","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Proost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marry M.","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen W.A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia R.","family":"Berkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2941-6179","authenticated-orcid":false,"given":"Jarno","family":"Drost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101878_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/pbc.22922","article-title":"Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: A report of the SIOP renal tumour study group","volume":"56","author":"Van den Heuvel-Eibrink","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.xcrm.2024.101878_bib2","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/00000478-199410000-00005","article-title":"The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy","volume":"18","author":"Parham","year":"1994","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.xcrm.2024.101878_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3171\/jns.1996.85.1.0056","article-title":"Central nervous system atypical teratoid\/rhabdoid tumors of infancy and childhood: definition of an entity","volume":"85","author":"Rorke","year":"1996","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.xcrm.2024.101878_bib4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xcrm.2024.101878_bib5","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.3390\/cancers14092185","article-title":"Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging Population","volume":"14","author":"Nemes","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2024.101878_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ccell.2016.11.003","article-title":"Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors","volume":"30","author":"Torchia","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101878_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/neuonc\/noz235","article-title":"Molecular subgrouping of atypical teratoid\/rhabdoid tumors\u2014a reinvestigation and current consensus","volume":"22","author":"Ho","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2024.101878_bib8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ccell.2016.02.009","article-title":"Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways","volume":"29","author":"Chun","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101878_bib9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/labinvest.2010.66","article-title":"Rhabdoid tumor: Gene expression clues to pathogenesis and potential therapeutic targets","volume":"90","author":"Gadd","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.xcrm.2024.101878_bib10","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1038\/s41467-021-23949-5","article-title":"Single cell derived mRNA signals across human kidney tumors","volume":"12","author":"Young","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101878_bib11","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41467-021-21675-6","article-title":"Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours","volume":"12","author":"Custers","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101878_bib12","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1172\/JCI64400","article-title":"A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers","volume":"122","author":"Lee","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101878_bib13","first-page":"74","article-title":"Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors","volume":"59","author":"Biegel","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101878_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00401-014-1323-x","article-title":"SMARCA4-mutated atypical teratoid\/rhabdoid tumors are associated with inherited germline alterations and poor prognosis","volume":"128","author":"Hasselblatt","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xcrm.2024.101878_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101878_bib16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nbt0816-794","article-title":"Cancer anabolic metabolism inhibitors move into clinic","volume":"34","author":"Garber","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2024.101878_bib17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd4145","article-title":"Metabolic targets for cancer therapy","volume":"12","author":"Galluzzi","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2024.101878_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101878_bib19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrneph.2017.59","article-title":"Metabolic reprogramming in clear cell renal cell carcinoma","volume":"13","author":"Wettersten","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.xcrm.2024.101878_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccell.2015.12.004","article-title":"An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma","volume":"29","author":"Hakimi","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101878_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbabio.2016.12.003","article-title":"Metabolic synthetic lethality in cancer therapy","volume":"1858","author":"Zecchini","year":"2017","journal-title":"Biochim. Biophys. Acta. Bioenerg."},{"key":"10.1016\/j.xcrm.2024.101878_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1195500","article-title":"Metabolic reprogramming of clear cell renal cell carcinoma","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.xcrm.2024.101878_bib23","series-title":"Clear Cell Renal Carcinoma","author":"Padala","year":"2023"},{"key":"10.1016\/j.xcrm.2024.101878_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098391","article-title":"PI3K\/AKT\/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL\/HIF Axis","volume":"24","author":"Badoiu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2024.101878_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jgg.2015.03.003","article-title":"The PI3K\/AKT Pathway and Renal Cell Carcinoma","volume":"42","author":"Guo","year":"2015","journal-title":"Journal of Genetics and Genomics"},{"key":"10.1016\/j.xcrm.2024.101878_bib26","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1039\/C5MB00101C","article-title":"The PI3K\/AKT\/mTOR interactive pathway","volume":"11","author":"Ersahin","year":"2015","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.xcrm.2024.101878_bib27","first-page":"153","article-title":"Oncogenic Roles of the PI3K\/AKT\/mTOR Axis","volume":"407","author":"Aoki","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.xcrm.2024.101878_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","article-title":"Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Motzer","year":"2022","journal-title":"J.\u00a0Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.xcrm.2024.101878_bib29","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1158\/1078-0432.CCR-19-0189","article-title":"Unbiased metabolic profiling predicts sensitivity of high MYC-expressing atypical teratoid\/rhabdoid tumors to glutamine inhibition with 6-diazo-5-oxo-L-norleucine","volume":"25","author":"Wang","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101878_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.gde.2013.11.012","article-title":"Organoid cultures for the analysis of cancer phenotypes","volume":"24","author":"Sachs","year":"2014","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.xcrm.2024.101878_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2024.101878_bib32","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2024.101878_bib33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101878_bib34","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid models of human and mouse ductal pancreatic cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101878_bib35","first-page":"1424","article-title":"Human Primary Liver Cancer\u2013Derived Organoid Cultures for Disease Modeling and Drug Screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101878_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101878_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41587-019-0048-8","article-title":"Tubuloids derived from human adult kidney and urine for personalized disease modeling","volume":"37","author":"Schutgens","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2024.101878_bib38","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41467-020-15155-6","article-title":"An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity","volume":"11","author":"Calandrini","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101878_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109568","article-title":"Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors","volume":"36","author":"Calandrini","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2024.101878_bib40","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216001","article-title":"Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes","volume":"14","author":"Meister","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2024.101878_bib41","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s41388-023-02681-y","article-title":"Atypical teratoid\/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities","volume":"42","author":"Paassen","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2024.101878_bib42","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMp1607591","article-title":"Toward a Shared Vision for Cancer Genomic Data","volume":"375","author":"Grossman","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101878_bib43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mpo.2950160502","article-title":"High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude total therapy study X","volume":"16","author":"Abromowitch","year":"1988","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.xcrm.2024.101878_bib44","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.1200\/JCO.2005.08.071","article-title":"Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102","volume":"23","author":"Hutchins","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101878_bib45","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1038\/s41598-020-80724-0","article-title":"High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials","volume":"11","author":"Yu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2024.101878_bib46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cam4.1898","article-title":"Safety and efficacy of high-dose methotrexate for osteosarcoma in adolescents compared with young adults","volume":"8","author":"Wippel","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.xcrm.2024.101878_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cam4.161","article-title":"Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012","volume":"3","author":"Slavc","year":"2014","journal-title":"Cancer Med."},{"key":"10.1016\/j.xcrm.2024.101878_bib48","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ccell.2022.07.011","article-title":"De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma","volume":"40","author":"Shi","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101878_bib49","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.ccell.2022.07.012","article-title":"A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma","volume":"40","author":"Pal","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101878_bib50","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.ccell.2022.10.009","article-title":"Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma","volume":"40","author":"Gwynne","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101878_bib51","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1038\/s41388-022-02517-1","article-title":"DHODH inhibition impedes glioma stem cell proliferation, induces DNA damage, and prolongs survival in orthotopic glioblastoma xenografts","volume":"41","author":"Spina","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2024.101878_bib52","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature22056","article-title":"Modulating the therapeutic response of tumours to dietary serine and glycine starvation","volume":"544","author":"Maddocks","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101878_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s40170-017-0169-9","article-title":"Bortezomib resistance in multiple myeloma is associated with increased serine synthesis","volume":"5","author":"Zaal","year":"2017","journal-title":"Cancer Metab."},{"key":"10.1016\/j.xcrm.2024.101878_bib54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D32311037244","article-title":"Does daily folic acid supplementation reduce methotrexate efficacy?","volume":"23","author":"Cline","year":"2017","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.xcrm.2024.101878_bib55","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/S1470-2045(13)70088-3","article-title":"Extracranial rhabdoid tumours: What we have learned so far and future directions","volume":"14","author":"Brennan","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2024.101878_bib56","unstructured":"Lowis S, Nicolin G, Pizer B, Clifford S, Anderson J. Guidelines for management of Atypical Teratoid Rhabdoid Tumours, version 2.2 Guidelines for management of Atypical Teratoid Rhabdoid Tumours CCLG Neuro-oncology Special Interest Group. Published online 2011."},{"key":"10.1016\/j.xcrm.2024.101878_bib57","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM194806032382301","article-title":"Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid","volume":"238","author":"Farber","year":"1948","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101878_bib58","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.3390\/ijms21103483","article-title":"Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers","volume":"21","author":"Ko\u017ami\u0144ski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2024.101878_bib59","doi-asserted-by":"crossref","first-page":"e29940","DOI":"10.1002\/pbc.29940","article-title":"Safety analysis of high-dose methotrexate in pediatric non-Hodgkin lymphomas","volume":"69","author":"Bernhardt","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.xcrm.2024.101878_bib60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mpo.2950150205","article-title":"A randomized study comparing high-dose methotrexate with moderate-dose methotrexate as components of adjuvant chemotherapy in childhood nonmetastatic osteosarcoma: A report from the childrens cancer study group","volume":"15","author":"Krailo","year":"1987","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.xcrm.2024.101878_bib61","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1200\/JCO.2005.06.031","article-title":"Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and\/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate","volume":"23","author":"Meyers","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101878_bib62","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1002\/1097-0142(19931201)72:11<3227::AID-CNCR2820721116>3.0.CO;2-C","article-title":"Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin","volume":"72","author":"Bacci","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2024.101878_bib63","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.ejca.2015.08.009","article-title":"Intraventricular methotrexate as part of primary therapy for children with infant and\/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy","volume":"51","author":"Pompe","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.xcrm.2024.101878_bib64","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1200\/JCO.1988.6.4.649","article-title":"Preradiation high-dose intravenous methotrexate with leucovorin rescue for untreated primary childhood brain tumors","volume":"6","author":"Allen","year":"1988","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101878_bib65","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/2018.10.PEDS18377","article-title":"Childhood brain tumors: Current management, biological insights, and future directions","volume":"23","author":"Pollack","year":"2019","journal-title":"J.\u00a0Neurosurg. Pediatr."},{"key":"10.1016\/j.xcrm.2024.101878_bib66","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-015-1878-y","article-title":"Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial","volume":"125","author":"Sandberg","year":"2015","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.xcrm.2024.101878_bib67","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4143\/crt.2020.756","article-title":"Atypical Teratoid\/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years","volume":"53","author":"Park","year":"2021","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.xcrm.2024.101878_bib68","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","article-title":"Preventing and Managing Toxicities of High-Dose Methotrexate","volume":"21","author":"Howard","year":"2016","journal-title":"Oncol."},{"key":"10.1016\/j.xcrm.2024.101878_bib69","first-page":"537","article-title":"Gemcitabine and Docetaxel for the Treatment of Relapsed and Refractory Malignant Rhabdoid Tumor of Kidney and Atypical Teratoid Rhabdoid Tumor","volume":"48","author":"Matsubara","year":"2021","journal-title":"Gan To Kagaku Ryoho."},{"key":"10.1016\/j.xcrm.2024.101878_bib70","article-title":"Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid\/rhabdoid tumors","volume":"5","author":"Metselaar","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2024.101878_bib71","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1038\/s41467-021-26395-5","article-title":"The impact of physiological metabolite levels on serine uptake, synthesis and utilization in cancer cells","volume":"12","author":"Hennequart","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101878_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1480613","article-title":"Bridging the gap: advancing cancer cell culture to reveal key metabolic targets","volume":"14","author":"Kes","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2024.101878_bib73","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cell.2017.03.023","article-title":"Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase","volume":"169","author":"Cantor","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101878_bib74","doi-asserted-by":"crossref","first-page":"eaau7314","DOI":"10.1126\/sciadv.aau7314","article-title":"Improving the metabolic fidelity of cancer models with a physiological cell culture medium","volume":"5","author":"Voorde","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2024.101878_bib75","doi-asserted-by":"crossref","first-page":"e81289","DOI":"10.7554\/eLife.81289","article-title":"Pancreatic tumors exhibit myeloid-driven amino acid stress and upregulate arginine biosynthesis","volume":"12","author":"Saab","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.xcrm.2024.101878_bib76","first-page":"291","article-title":"Quantification of histochemical staining by color deconvolution","volume":"23","author":"Ruifrok","year":"2001","journal-title":"Anal. Quant. Cytol. Histol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124006499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124006499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T04:10:51Z","timestamp":1740888651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124006499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2666379124006499"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101878","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic profiling of patient-derived organoids reveals nucleotide synthesis as a metabolic vulnerability in malignant rhabdoid tumors","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101878"}}